Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Endothelial Dysfunction Market Forecast to 2028 - Global Analysis by Cause (Hypertension, Diabetes, Hypercholestrolaemia, Bechet’s Disease, Obesity, and Others), Test Type [Invasive Tests and Non-Invasive Tests (Flow Mediated Dilatory, Peripheral Arterial Tonometry (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others)
... Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others) The global endothelial dysfunction market size was valued at US$ 1,995.17 million in 2022 and is expected to reach ... Read More
-
Oman Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... million by 2028, at a CAGR of 6.61% during the forecast period (2023-2028). The market is estimated to reach a value of more than USD 258 million by 2027. The COVID-19 pandemic positively impacted the ... Read More
-
United States Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023 to USD 37.69 billion by 2028, at a CAGR of 3.70% during the forecast period (2023-2028). COVID-19 has carved an especially fatal route through the 1 in 10 diabetics in the United States, including ... Read More
-
Brazil Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 1.94 billion by 2028, growing at a CAGR of 4.10% during the forecast period (2023-2028). Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older ... Read More
-
North America Sulfonylureas Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 3.35 billion by 2028, growing at a CAGR of 1.90% during the forecast period (2023-2028). The market is estimated to reach a value of more than USD 3.2 billion by 2027. The COVID-19 pandemic ... Read More
-
Iran Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 386.81 million by 2028, growing at a CAGR of 3.90% during the forecast period (2023-2028). Inadequate preventive measures interrupted traditional methods of relationship with the patient, medication shortages, disruption of routine diabetic ... Read More
-
Europe Insulin Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 7.20 billion by 2028, growing at a CAGR of 4.89% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the European Insulin Drugs Market. Type-1 diabetes patients are impacted more during Covid-19. ... Read More
-
Oman Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 73 million by 2028, at a CAGR of 2.77% during the forecast period (2023-2028). The market is estimated to reach a value of more than USD 71 million by 2027. The COVID-19 pandemic positively ... Read More
-
North America Human Insulin Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... is expected to reach USD 13.50 billion by 2028, growing at a CAGR of 3.91% during the forecast period (2023-2028). In North America diabetes incidence for type 2 diabetes as well as other diabetes, forms ... Read More
-
Australia Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 776 million by 2028, growing at a CAGR of 2.46% during the forecast period (2023-2028). The COVID-19 pandemic positively impacted the Australia Diabetes Care Devices Market growth. Patients with diabetes, infected with ... Read More
-
North America Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023 to USD 18.49 billion by 2028, at a CAGR of 5.06% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the North America Insulin Delivery Devices Market. Type-1 diabetes patients are impacted ... Read More
-
South Korea Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... is expected to reach USD 514.43 million by 2028, growing at a CAGR of 3% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the diabetes care devices market. The prevalence of diabetes ... Read More
-
Japan Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 9.56 billion by 2028, growing at a CAGR of 3.07% during the forecast period (2023-2028). The COVID-19 pandemic has had a substantial impact on the diabetes care devices market. The prevalence of ... Read More
-
North America Insulin Pens Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 14.64 billion by 2028, growing at a CAGR of 4.87% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the North America Insulin Pens Market. Type-1 diabetes patients are impacted ... Read More
-
Asia-Pacific Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 26.13 billion by 2028, growing at a CAGR of 3.50% during the forecast period (2023-2028). Japan holds the highest market share in the Asia-Pacific Diabetes Care Devices Market and is expected to ... Read More
-
Insulin Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion by 2028, growing at a CAGR of 3.87% during the forecast period (2023-2028). The COVID-19 pandemic has had a substantial impact on the Human Insulin Drugs Market. Type-1 diabetes patients are impacted more during ... Read More
-
Egypt Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 442 million by 2028, at a CAGR of 3.36% during the forecast period (2023-2028). The market is estimated to reach a value of more than USD 430 million by 2027. The COVID-19 pandemic positively ... Read More
-
India Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... reach USD 2.41 billion by 2028, growing at a CAGR of 2.28% during the forecast period (2023-2028). According to the Article Published in “THE HINDU” One in six people with diabetes in the world is ... Read More
-
United Kingdom Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... in 2023 to USD 1.09 billion by 2028, at a CAGR of 6.72% during the forecast period (2023-2028). The COVID-19 pandemic had a substantial impact on the United Kingdom's diabetes care devices. According to The ... Read More
-
North America Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... is expected to reach USD 35.02 billion by 2028, growing at a CAGR of 6.21% during the forecast period (2023-2028). In North America, till April 2022, the United States is having the highest COVID cases ... Read More
-
Latin America Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... is expected to reach USD 2.1 billion by 2028, growing at a CAGR of 5.64% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the Latin America Diabetes Care Devices Market. People with ... Read More
-
Philippines Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 101.68 million by 2028, at a CAGR of 4.70% during the forecast period (2023-2028). COVID-19 is a new illness caused by a strain of the SARS-CoV-2 virus. Most patients infected with the virus will ... Read More
-
North America Insulin Syringe Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 272.83 million by 2028, growing at a CAGR of 1.70% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the North America Insulin Syringe Market. People with diabetes have a ... Read More
-
Europe Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 8.41 billion by 2028, at a CAGR of 3.40% during the forecast period (2023-2028). The COVID-19 epidemic significantly influenced the European Diabetes Medicines Market. As people with diabetes already have weakened immune systems, COVID-19 ... Read More
-
Latin America Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023 to USD 3.73 billion by 2028, at a CAGR of 3.50% during the forecast period (2023-2028). The ability to react to and adapt to populations, governments, and health systems around the world was put ... Read More
Research Assistance
